MOLECULAR TEMPLATES
Molecular Templates is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.
MOLECULAR TEMPLATES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2000-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.mtem.com
Total Employee:
11+
Status:
Active
Contact:
5122332709
Email Addresses:
[email protected]
Total Funding:
298.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Microsoft Exchange Online
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-08-02 | Threshold Pharmaceuticals | Threshold Pharmaceuticals acquired by Molecular Templates | N/A |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Debt - Molecular Templates
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Molecular Templates
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - Molecular Templates
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Molecular Templates
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Molecular Templates
CAM Capital
CAM Capital investment in Post-IPO Equity - Molecular Templates
Takeda
Takeda investment in Post-IPO Equity - Molecular Templates
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Molecular Templates
Sante Ventures
Sante Ventures investment in Series D - Molecular Templates
Aju IB Investment
Aju IB Investment investment in Series C - Molecular Templates
Official Site Inspections
http://www.mtem.com Semrush global rank: 2.39 M Semrush visits lastest month: 7.69 K
- Host name: 209.182.196.37
- IP address: 209.182.196.37
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Molecular Templates"
Molecular Templates, Inc.
Any questions may be submitted by email to: [email protected] Previous SEC filings for the Company can be found at: https://www.sec.gov Correspondence …See details»
Molecular Templates Inc (MTEM) Profile - The Globe and Mail
See the company profile for Molecular Templates Inc (MTEM) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Molecular Templates - Crunchbase Company Profile
Stock Symbol NASDAQ:MTEM . Company Type For Profit. Founders Leigh …See details»
Molecular Templates (MTEMQ) Company Profile & Description
Jul 21, 2025 Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other …See details»
Molecular Templates, Inc. (MTEM) - Yahoo Finance Canada
Molecular Templates, Inc. (MTEM) Follow. Add holdings . 0.0001 0.0000 (0.00%) At close: June 5 at 8:00:00 p.m. EDT . General ; Hiring Trends . Key Executives . Amounts are as of December …See details»
Mtem - 2025 Company Profile & Team - Tracxn
Jun 16, 2025 Mtem is an acquired company based in Edinburgh (United Kingdom), founded in 2004 by Anton Ziolkowski. It operates as a Developer of next-gen immunotoxins for cancer. …See details»
Molecular Templates, Inc. - Drug pipelines, Patents, Clinical trials ...
Jul 6, 2025 AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage …See details»
Molecular Templates - Overview, News & Similar companies
Jun 3, 2024 Molecular Templates, Inc. Provides Interim Update AUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” …See details»
Home | Middle Tennessee Electric
Middle Tennessee Electric is a member-owned, not-for-profit electric cooperative that serves more than 230,000 meters in a four-county area south of metropolitan Nashville. We provide energy …See details»
Molecular Templates - Company Profile & Staff Directory
Molecular Templates is a Biotechnology company located in 9301 Amberglen Blvd, Suite 100, Austin, Texas 78729, US with 211 employees. Access Molecular Templates's email format …See details»
Molecular Templates - PitchBook
Molecular Templates General Information Description. Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing …See details»
Molecular Templates - Craft
Oct 29, 2024 Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer and …See details»
Molecular Templates (MTEMQ) Stock Price & Overview - Stock …
Jul 21, 2025 Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules. AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular …See details»
About Us
About Us. Founded in 2018, MTEM has grown from a startup with IoT innovations to a cybersecurity and digital marketing powerhouse. We work closely with global OEMs, Tier 1 …See details»
Molecular Templates Inc (MTEM) Directors and Executive Officers
Gabriela Gruia, M.D. Director Harold E. Selick, Ph.D. Director Kevin Lalande Director Jason S. Kim Chief Financial Officer (Principal Financial and Accounting Officer)See details»
MTEM - Molecular Templates Inc Latest Stock News & Market …
Company Overview. Molecular Templates Inc (MTEM) is a clinical-stage biopharmaceutical company dedicated to the discovery and development of targeted biologic therapeutics. At its …See details»
Molecular Templates Inc (MTEM) Profile, Company FAQs
52 week high is the highest price of a stock in the past 52 weeks, or one year. Molecular Templates Inc 52 week high is $1.59 as of June 13, 2025.See details»
Molecular Templates Announces Notice of Delisting and Failure to ...
AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage …See details»
Molecular Templates | BIOTECHNOLOGY REPORT
Molecular Templates (MTEM) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) …See details»
MTEM Ltd. - VentureRadar
Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of the next generation of immunotoxins... ... Find out more ...See details»